Related Experiment Video
Updated: Sep 1, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Anti-Hypertensive Activity of Some Selected Unani Formulations: An Evidence-Based Approach for Verification of
Md Adil Shaharyar1, Rudranil Bhowmik1, Obaid Afzal2
1Bioequivalence Study Centre, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, West Bengal, India.
Insights
This study investigated Unani formulations for hypertension using the L-NAME model. DMM formulation significantly reduced systolic blood pressure and plasma nitrite, suggesting potential anti-hypertensive activity via NO inhibition.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Traditional Medicine
Background:
- Systemic arterial hypertension is a major global risk factor for cardiovascular disease (CVD) and mortality.
- The World Health Organization recognizes Unani medicine as an alternative system of medicine.
- Identifying effective anti-hypertensive agents is crucial for public health.
Purpose of the Study:
- To evaluate the anti-hypertensive effects of selected Unani formulations.
- To investigate the efficacy of these formulations in an L-NAME induced hypertension model.
- To explore potential mechanisms of action, including effects on plasma biomarkers.
Main Methods:
- The study utilized the L-NAME model to induce hypertension in rats.
- Six groups were treated with different Unani formulations (KAS, DMM, MSR, HJ, KGS) or vehicle.
- Systolic blood pressure, RR-interval, and plasma levels of sodium, potassium, nitrite, ANP, adrenaline, noradrenaline, and aldosterone were measured using LC-MS/MS.
Main Results:
- The DMM formulation significantly reduced systolic blood pressure (p < 0.05) and plasma nitrite levels.
- KAS, MSR, and HJ formulations showed non-significant reductions in systolic blood pressure.
- KGS formulation increased systolic blood pressure, while DMM and KGS significantly increased potassium levels. Adrenaline and noradrenaline levels also changed significantly with DMM and KGS treatments.
Conclusions:
- The Unani formulation DMM demonstrated significant anti-hypertensive activity, potentially mediated through nitric oxide (NO) inhibition.
- Other formulations (KAS, MSR, HJ) showed minimal effects, while KGS may act through central sympathomimetic mechanisms.
- Further research into DMM's anti-hypertensive properties and mechanisms is warranted.
Abstract:
Background: Systemic arterial hypertension, which is associated with an increased risk of cardiovascular disease(CVD), is the most significant modifiable risk factor for mortality and morbidity worldwide. WHO has recognized Unanipathy as an alternate system of medicine. The aim of the present study is to investigate the anti-hypertensive activity of some selected unani formulations using L-NAME model. Method: Group I or hypertensive control group: L-NAME administered for 7 days and left for the next 7 days; Group II or KASgroup: L-NAME administered (i.p) for 7 days and L-NAME + KAS (1000 mg/kg b.w) for the next 7 days; Group III or DMM group: L-NAME administered (i.p) for 7 days and L-NAME + DMM (2000 mg/kg b.w) for the next 7 days; Group IV or MSR group: L-NAME administered (i.p) for 7 days and L-NAME + MSR (300 mg/kg b.w) for the next 7 days; Group V or HJ group: L-NAME administered (i.p) for 7 days and L-NAME + HJ (113 mg/kg b.w) for the next 7 days; Group VI or KGS group: L-NAME administered (i.p) for 7 days and L-NAME +KGS (2000 mg/kg b.w) for the next 7 days. Non-invasive systolic blood pressure and RR-interval (ECG) was measured. Plasma was investigated forsodium, potassium, nitrite, ANP, adrenaline, noradrenaline and aldosterone on day 0, 7 and 14 using LC-MS/MS. Result: Treatment showed a non-significant lowreduction in SBP (systolic blood pressure) of KAS, MSR and HJ while that of DMM was quite significant (p < 0.05), but in the case of KGS, SBP increased. DMM on day 14 significantly (p < 0.05) reduced plasma nitrite while no significant plasma Na+ was noted. In the case of both DMM and KGS, potassium increased significantly (p < 0.05) on day 14. No significant changes in plasma ANP and aldosterone was observed against DMM and KGS while blood levels of adrenaline and noradrenaline significantly (p < 0.05) changed. No significant change in body weight was found. Conclusions: L-NAME KAS, MSR and HJ showed no change in SBP while DMM showed a significant reduction in SBP with decreased plasma nitrite. Probably, DMM may have anti-hypertensive activity mediated through NO inhibition while KGS may involve central sympathomimetic action.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Antihypertensive Drugs: Direct Renin Inhibitors
Hypertension IV: Drug Therapy and Lifestyle Modifications